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Identity 
Other names: E1A-F; E1AF; PEA3; PEAS3 




The gene spans approximately 30 kb and contained 14 
exons. The largest exon (901 bp) contains the end of 
the ETS domain, the carboxy-terminal domain and the 
3'-untranslated region. The remaining exons varied 
from 48 bp (exon 5) to 266 bp (exon 9). 
Protein 
Description 
ETV4 is a member of ets-oncogene family transcription 
factors that were cloned by the ability to bind to 
enhancer motifs of the adenovirus E1A gene (Lavia et 
al., 2003). It is composed of 555 amino acids, which 
has a molecular weight ranging 61~70 kDa. 
Localisation 
Nuclear (Monté et al., 1994; Takahashi et al., 2005). 
Ubiquitinated protein is localized in the dot-like 
structure in the nuclear (Takahashi et al., 2005). 
Function 
ETV4 is capable of regulating transcription by binding 
to the Ets-binding site in the promoter of its target 
genes. Biologically, it contributes in a number of 
processes including neuronal pathfinding, mammary 
gland development, and male sexual function (Laing et 
al., 2000; Ladle et al., 2002; Kurpios et al., 2003). In 
various malignancies, its over-expression has been 
observed and it was also associated with tumor 
progression and outcome of patients with these 
malignancies. As mechanism of such function, 
regulation of hepatocyte growth factor (HGF)-induced 
cell migration (Hakuma et al., 2005), HER2-mediated 
malignant potential (Benz et al., 1997), and other 
ETV4-related factors including cyclooxygenase 
(COX)-2 and matrix metalloproteinases (MMPs) have 
been reported (Higashino et al., 1995; Horiuchi et al., 
2003; Shindoh et al., 2004).  
 
GeneLoc map region. 
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In addition, ETV4 promotes cell cycle progression via
upregulation of cyclin D3 transcription in breast can er 
cell (MDA231 cell) (Jiang et al., 2007). In contrast, 
ETV4 function as negative regulator of sonic hedgehog 




Over-expression of ETV4 has been detected in human 
cancer cell lines (Baert et al., 1997). In animal model 
and human tissues, its over-expression was also found 
and it was associated with malignant potential 
including invasion and metastasis (Trimble et al., 1993; 
De Launoit et al., 2000; Benz et al., 1997; Bièche et al., 
2004). Such ETV4-related functions are controlled via 
regulation of cyclin D3 transcription (Jiang et al., 
2007), HER-2/Neu (Benz et al., 1997), and MMPs 
(Bièche et al., 2004). 
Gastric cancer 
Disease 
Correlated with tumor progression via up-regulation of 
matrilysin in human tissues (Yamamoto et al., 2004). 
Lung cancer 
Disease 
ETV4 expression was not detected in normal lung 
tissues. On the other hand, it is expressed in distal lung 
epithelium during lung development and in human lung 
cancer cells (Hiroumi et al., 2001; Liu et al., 2003). It 
was reported to be associated with cell invasion 
(Hiroumi et al., 2001) and metastasis via regulation of 
caveolin-1 transcription (Sloan et al., 2009) and Met-
related factors (Hakuma et al., 2005). 
Malignant melanoma 
Disease 
In cell lines, ETV4 plays important roles for malignant 
behavior including invasion and metastasis thorough 
up-regulation of MT1-MMP (Hata et al., 2008). 
Prostate cancer 
Disease 
In human tissues, its expression in cancer cell was
significantly higher than that in normal cells and it was 
also positively associated with pT stage. This finding 
was influenced with regulation of MMP-7 and MMP-9, 
but not of MMP-1, MMP-3, and MMP-14 (MT1-
MMP) (Maruta et al., 2009). 
Colorectal cancer 
Disease 
In early stage of colorectal carcinogenesis, its over-
expression plays important roles through MMPs, COX-













Atlas Genet Cytogenet Oncol Haematol. 2011; 15(7)  556 
References 
Trimble MS, Xin JH, Guy CT, Muller WJ, Hassell JA. PEA3 is 
overexpressed in mouse metastatic mammary 
adenocarcinomas. Oncogene. 1993 Nov;8(11):3037-42 
Monté D, Baert JL, Defossez PA, de Launoit Y, Stéhelin D. 
Molecular cloning and characterization of human ERM, a new 
member of the Ets family closely related to mouse PEA3 and 
ER81 transcription factors. Oncogene. 1994 May;9(5):1397-
406 
Higashino F, Yoshida K, Noumi T, Seiki M, Fujinaga K. Ets-
related protein E1A-F can activate three different matrix 
metalloproteinase gene promoters. Oncogene. 1995 Apr 
6;10(7):1461-3 
Baert JL, Monté D, Musgrove EA, Albagli O, Sutherland RL, de 
Launoit Y. Expression of the PEA3 group of ETS-related 
transcription factors in human breast-cancer cells. Int J 
Cancer. 1997 Mar 4;70(5):590-7 
Benz CC, O'Hagan RC, Richter B, Scott GK, Chang CH, Xiong 
X, Chew K, Ljung BM, Edgerton S, Thor A, Hassell JA. 
HER2/Neu and the Ets transcription activator PEA3 are 
coordinately upregulated in human breast cancer. Oncogene. 
1997 Sep 25;15(13):1513-25 
de Launoit Y, Chotteau-Lelievre A, Beaudoin C, Coutte L, 
Netzer S, Brenner C, Huvent I, Baert JL. The PEA3 group of 
ETS-related transcription factors. Role in breast cancer 
metastasis. Adv Exp Med Biol. 2000;480:107-16 
Laing MA, Coonrod S, Hinton BT, Downie JW, Tozer R, 
Rudnicki MA, Hassell JA. Male sexual dysfunction in mice 
bearing targeted mutant alleles of the PEA3 ets gene. Mol Cell 
Biol. 2000 Dec;20(24):9337-45 
Hiroumi H, Dosaka-Akita H, Yoshida K, Shindoh M, Ohbuchi T, 
Fujinaga K, Nishimura M. Expression of E1AF/PEA3, an Ets-
related transcription factor in human non-small-cell lung 
cancers: its relevance in cell motility and invasion. Int J 
Cancer. 2001 Sep;93(6):786-91 
Ladle DR, Frank E. The role of the ETS gene PEA3 in the 
development of motor and sensory neurons. Physiol Behav. 
2002 Dec;77(4-5):571-6 
Horiuchi S, Yamamoto H, Min Y, Adachi Y, Itoh F, Imai K. 
Association of ets-related transcriptional factor E1AF 
expression with tumour progression and overexpression of 
MMP-1 and matrilysin in human colorectal cancer. J Pathol. 
2003 Aug;200(5):568-76 
Kurpios NA, Sabolic NA, Shepherd TG, Fidalgo GM, Hassell 
JA. Function of PEA3 Ets transcription factors in mammary 
gland development and oncogenesis. J Mammary Gland Biol 
Neoplasia. 2003 Apr;8(2):177-90 
Lavia P, Mileo AM, Giordano A, Paggi MG. Emerging roles of 
DNA tumor viruses in cell proliferation: new insights into 
genomic instability. Oncogene. 2003 Sep 29;22(42):6508-16 
Liu Y, Jiang H, Crawford HC, Hogan BL. Role for ETS domain 
transcription factors Pea3/Erm in mouse lung development. 
Dev Biol. 2003 Sep 1;261(1):10-24 
Bièche I, Tozlu S, Girault I, Onody P, Driouch K, Vidaud M, 
Lidereau R. Expression of PEA3/E1AF/ETV4, an Ets-related 
transcription factor, in breast tumors: positive links to MMP2, 
NRG1 and CGB expression. Carcinogenesis. 2004 
Mar;25(3):405-11 
Shindoh M, Higashino F, Kohgo T. E1AF, an ets-oncogene 
family transcription factor. Cancer Lett. 2004 Dec 8;216(1):1-8 
Yamamoto H, Horiuchi S, Adachi Y, Taniguchi H, Nosho K, 
Min Y, Imai K. Expression of ets-related transcriptional factor 
E1AF is associated with tumor progression and over-
expression of matrilysin in human gastric cancer. 
Carcinogenesis. 2004 Mar;25(3):325-32 
Hakuma N, Kinoshita I, Shimizu Y, Yamazaki K, Yoshida K, 
Nishimura M, Dosaka-Akita H. E1AF/PEA3 activates the 
Rho/Rho-associated kinase pathway to increase the 
malignancy potential of non-small-cell lung cancer cells. 
Cancer Res. 2005 Dec 1;65(23):10776-82 
Nosho K, Yoshida M, Yamamoto H, Taniguchi H, Adachi Y, 
Mikami M, Hinoda Y, Imai K. Association of Ets-related 
transcriptional factor E1AF expression with overexpression of 
matrix metalloproteinases, COX-2 and iNOS in the early stage 
of colorectal carcinogenesis. Carcinogenesis. 2005 
May;26(5):892-9 
Takahashi A, Higashino F, Aoyagi M, Yoshida K, Itoh M, 
Kobayashi M, Totsuka Y, Kohgo T, Shindoh M. E1AF 
degradation by a ubiquitin-proteasome pathway. Biochem 
Biophys Res Commun. 2005 Feb 11;327(2):575-80 
Jiang J, Wei Y, Liu D, Zhou J, Shen J, Chen X, Zhang S, Kong 
X, Gu J. E1AF promotes breast cancer cell cycle progression 
via upregulation of Cyclin D3 transcription. Biochem Biophys 
Res Commun. 2007 Jun 22;358(1):53-8 
Hata H, Kitamura T, Higashino F, Hida K, Yoshida K, Ohiro Y, 
Totsuka Y, Kitagawa Y, Shindoh M. Expression of E1AF, an 
ets-oncogene transcription factor, highly correlates with 
malignant phenotype of malignant melanoma through up-
regulation of the membrane-type-1 matrix metalloproteinase 
gene. Oncol Rep. 2008 May;19(5):1093-8 
Mao J, McGlinn E, Huang P, Tabin CJ, McMahon AP. Fgf-
dependent Etv4/5 activity is required for posterior restriction of 
Sonic Hedgehog and promoting outgrowth of the vertebrate 
limb. Dev Cell. 2009 Apr;16(4):600-6 
Maruta S, Sakai H, Kanda S, Hayashi T, Kanetake H, Miyata 
Y. E1AF expression is associated with extra-prostatic growth 
and matrix metalloproteinase-7 expression in prostate cancer. 
APMIS. 2009 Nov;117(11):791-6 
Sloan KA, Marquez HA, Li J, Cao Y, Hinds A, O'Hara CJ, 
Kathuria S, Ramirez MI, Williams MC, Kathuria H. Increased 
PEA3/E1AF and decreased Net/Elk-3, both ETS proteins, 
characterize human NSCLC progression and regulate 
caveolin-1 transcription in Calu-1 and NCI-H23 NSCLC cell 
lines. Carcinogenesis. 2009 Aug;30(8):1433-42 
This article should be referenced as such: 
Miyata Y. ETV4 (ets variant 4). Atlas Genet Cytogenet Oncol 
Haematol. 2011; 15(7):554-556. 
